Background
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain.• Molecular cloning and expression analysis of GFR alpha-3, a novel cDNA related to GDNFR alpha and NTNR alpha., PMID:9535755• GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin., PMID:9740802• GDNF and NGF family members and receptors in human fetal and adult spinal cord and dorsal root ganglia., PMID:11745618• Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase., PMID:9608533• Glial cell line-derived neurotrophic factor is expressed in penis of adult rat and retrogradely transported in penile parasympathetic and sensory nerves., PMID:11151444• The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunction., PMID:15204970